Innovative Solutions In The Drugs Of Abuse Testing Market Are Software-As-A-Service (SAAS) Platforms For Enhanced Drug Discovery And Development Is Affecting The Direction Of The Drugs of Abuse (DOA) Testing Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Size Of The Drugs of Abuse (DOA) Testing Market In 2026 And How Much Will It Reach By 2030?
The drugs of abuse (doa) testing market size has experienced strong growth in recent years. It is anticipated to increase from $7.97 billion in 2025 to $8.68 billion in 2026, with a compound annual growth rate (CAGR) of 9.0%. This historical growth can be attributed to several factors including workplace safety regulations, the prevalence of substance abuse, the demand for criminal justice screening, the adoption of immunoassay testing, and the expansion of laboratory infrastructure.
The drugs of abuse (doa) testing market size is projected for substantial expansion in the coming years. This market is anticipated to reach a valuation of $12.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. The growth during the forecast period is attributable to several factors, including the demand for remote workplace testing, the expansion of oral fluid testing, real-time data integration, increased regulatory enforcement, and public health monitoring programs. Key trends expected over the forecast period encompass the increasing uptake of workplace drug screening programs, a surging need for rapid point-of-care testing, the proliferation of multi-panel drug testing kits, greater reliance on laboratory confirmation testing, and the incorporation of digital reporting and data management systems.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp
What Influential Factors Are Boosting The Drugs of Abuse (DOA) Testing Market Demand?
The projected expansion of the drugs of abuse (DOA) testing market is anticipated to be driven by the rising need for drug abuse treatment. Drug or substance abuse involves consuming a substance in amounts detrimental to oneself or others. Drug testing facilitates the detection of compounds not naturally present in the body. The methodology typically commences with a screening test, succeeded by a confirmatory test to ascertain or verify the presence of a substance or substances, directly linking to how the escalating demand for drug abuse treatment is set to boost market growth. For instance, a report from December 2023 by the Government of the United Kingdom (GOV. UK), a UK-based government platform, indicated that from April 2022 to March 2023, 290,635 adults sought drug and alcohol services, representing a modest rise from 289,215 in the prior year. Additionally, treatment admissions climbed to 137,749, surpassing the 130,490 and 133,704 recorded in the two preceding years. This evidence further solidifies that the growing requirement for drug abuse treatment is a significant impetus for the drug of abuse (DOA) testing market.
How Is The Drugs of Abuse (DOA) Testing Market Distributed Across Key Segments?
The drugs of abuse (doa) testing market covered in this report is segmented –
1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users
Subsegments:
1) By Analyzers: Immunoassay Analyzers, Chromatography-Based Analyzers, Mass Spectrometry Systems
2) By Rapid Testing Devices: Urine Test Kits, Saliva Test Kits, Hair Test Kits
3) By Consumables: Test Strips, Reagents, Sample Collection Devices
4) By Laboratory Services: Toxicology Testing, Confirmation Testing, Screening Services
Which Trends Are Contributing To Changes In The Drugs of Abuse (DOA) Testing Market?
Major companies within the drugs of abuse (DOA) testing market are prioritizing the creation of innovative products like software-as-a-service (SaaS) platforms to boost testing efficiency, enhance data handling, and strengthen their competitive standing. A software-as-a-service (SaaS) platform denotes a cloud-based application, managed by a third-party provider and accessed via the internet, which enables users to streamline operations, analyze complex data, and gain actionable intelligence without requiring local software installation. For example, in December 2023, Merck KGaA, a US-based science and technology company, introduced Addison, an advanced software platform for drug discovery. This platform integrates computer-aided drug design, machine learning, and generative AI to expedite drug development. Addison provides synthesis recommendations for virtual molecules, bridges digital drug design with practical manufacturability, and reveals concealed insights from vast datasets, ultimately improving the probability of delivering effective new therapies to patients.
Who Are The Firms Contributing To The Drugs of Abuse (DOA) Testing Market Ecosystem?
Major companies operating in the drugs of abuse (doa) testing market are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories
Access The Complete Drugs of Abuse (DOA) Testing Market Report:
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report
Which Region Accounts For The Highest Share Of The Drugs of Abuse (DOA) Testing Market?
North America was the largest region in the drugs of abuse (DOA) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Drugs of Abuse (DOA) Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=9381&type=smp
Browse Through More Reports Similar to the Global Drugs of Abuse (DOA) Testing Market 2026, By The Business Research Company
Drug Screening Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Cannabis Testing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cannabis-testing-global-market-report
Pharma Admet Testing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
